Citation sources

Updated weekly. Details via Crossref
Crossref Scopus Google Scholar
14 14 Search
2024
Multiomics characterization of pyroptosis in the tumor microenvironment and therapeutic relevance in metastatic melanoma
BMC Medicine
2023
A comprehensive signature based on endoplasmic reticulum stress-related genes in predicting prognosis and immunotherapy response in melanoma
Scientific Reports
2023
Manf Enhances the Pyroptosis Inhibition of Bone Marrow-derived Mesenchymal Stem Cells to Relieve Cerebral Infarction Injury
Neuroscience
2023
Clinical-mediated discovery of pyroptosis in CD8+ T cell and NK cell reveals melanoma heterogeneity by single-cell and bulk sequence
Cell Death & Disease
2023
The Therapeutic Potential of Pyroptosis in Melanoma
International Journal of Molecular Sciences
2022
Pan-cancer analyses of pyroptosis with functional implications for prognosis and immunotherapy in cancer
Journal of Translational Medicine
2022
The clinical significance of integrin subunit alpha V in cancers: from small cell lung carcinoma to pan-cancer
BMC Pulmonary Medicine
2022
Comprehensive characterisation of immunogenic cell death in melanoma revealing the association with prognosis and tumor immune microenvironment
Frontiers in Immunology
2022
A combined aging and immune prognostic signature predict prognosis and responsiveness to immunotherapy in melanoma
Frontiers in Pharmacology
2022
A Novel Pyroptotic and Inflammatory Gene Signature Predicts the Prognosis of Cutaneous Melanoma and the Effect of Anticancer Therapies
Frontiers in Medicine
2022
Pan-Cancer Pyroptosis Analyses Identified Novel Immunology and Chemotherapy-Related Prognostic Signatures in Cancer Subtypes
Journal of Oncology
2022
Development and Validation of a Combined Ferroptosis and Immune Prognostic Model for Melanoma
Journal of Oncology
2022
Identification of a predictive gene signature related to pyroptosis for the prognosis of cutaneous melanoma
Medicine
2022
Pancancer transcriptomic profiling identifies key PANoptosis markers as therapeutic targets for oncology
NAR Cancer